Venture capital outperforms alternatives in growth returns

Venture capital does outperform many alternatives in growth returns, but the lead is uneven and often narrow once the full path of cash and risk is counted. The cleanest public benchmarks still show venture ahead of broad private equity and, in some periods, ahead of listed market proxies for fast-growing companies.

What matters first is the shape of the return. In 2025, the Cambridge Associates U.S. Venture Capital Index returned 21.1%, while the broader U.S. Private Equity Index returned 8.7%. That is a wide gap for one year, and it tells the same basic story seen in other recent data: venture can deliver very strong gains when the best companies reprice upward and exits improve.

I am careful with that sentence, because “venture capital” is not one thing. The top line often comes from a small set of large winners, while many funds and many deals do far less well. Recent reporting from PitchBook also warns that headline returns can lean on unrealized marks, not just cash that has come back to investors. That is a real difference. Paper gains can look rich long before they turn into real distributions.

The comparison with alternatives also depends on which alternatives are in view. If the yardstick is public growth stocks, venture has had stretches where it lagged and stretches where it led. Cambridge Associates’ long-run benchmark work shows U.S. venture capital has produced strong multi-year returns, but the public-market comparison is not a free lunch. The benchmark’s own mPME analysis, which tries to compare venture with public indices, shows that venture does not beat public markets in every period.

That is the part many people miss. A good story about growth is not the same as a durable business. Venture rewards rare outcomes, not steady ones. The return pattern is lumpy, and it depends on pricing, exit windows, and how much capital the winners absorb before they mature.

The recent cycle also helps explain why the answer can look better now than it did a few years ago. Venture investment and fundraising recovered, and 2025 brought stronger performance in the benchmark data. MSCI’s private capital summary for early 2026 also showed venture leading private equity again in the quarter, which supports the idea that growth capital has regained some strength after a weak stretch. Still, one strong year does not make a stable rule.

There is another limit that deserves plain language. Venture returns are usually reported on an internal rate of return basis, which gives weight to both timing and valuation changes. That can make early marks look better than final cash results. If exits stay slow, or if a lot of paper value never clears into sales or listings, the published return can soften later.

So the honest answer is this: venture capital has outperformed many alternatives in growth returns, especially in the best years and in the best funds. The edge is real, but it is not broad, steady, or guaranteed. It comes from a few strong outcomes, a favorable exit market, and a lot of patience between financing rounds and liquidity.

For me, the useful question is not whether venture always wins. It is what kind of growth business can survive long enough to matter, and what kind of capital structure gives it time without confusing hope for proof. That is the thread I keep pulling on, because the headline is only useful if it stays tied to how the business actually works.

That is also where The GreenGold Ledger earns its keep. It looks past the pitch and into the business choices, capital signals, and policy shifts that decide whether growth becomes value.